BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1432 related articles for article (PubMed ID: 24388213)

  • 1. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of bradykinin: a major contributor to the innate inflammatory response.
    Joseph K; Kaplan AP
    Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
    Kaplan AP
    J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
    Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
    Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bradykinin-forming cascade and its role in hereditary angioedema.
    Kaplan AP; Joseph K
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1851-9. PubMed ID: 12489799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency.
    Miyata T; Horiuchi T
    Allergol Int; 2023 Jul; 72(3):375-384. PubMed ID: 37169642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
    Joseph K; Tuscano TB; Kaplan AP
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):279-86. PubMed ID: 18814451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
    Wedner HJ
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
    Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
    Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.